ExLibris header image
SFX Logo
Title: A Bayesian decision support tool for efficient dose individualization of warfarin in adults and children
Source:

Bmc Medical Informatics and decision Making [1472-6947] yr:2015


Collapse list of basic services Basic
Full text
Full text available via DOAJ Directory of Open Access Journals
GO
Full text available via PubMed Central
GO
Full text available via PubMed Central Open Access
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Gaynor, C. "A comparison of the prediction accuracy of two IVIVC modelling techniques." Journal of pharmaceutical sciences 97.8 (2008): 3422-3432. Link to Full Text for this item Link to SFX for this item
2. Miao, L. "Contribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patients." European journal of clinical pharmacology 63.12 (2007): 1135-41. Link to Full Text for this item Link to SFX for this item
3. Raskob, Gary E. "Oral anticoagulants: New and improved." Blood 124.12 (2014): 1851-1852. Link to SFX for this item
4. Bonate, Peter L. Pharmacokinetic-Pharmacodynamic Modeling and Simulation. Springer US :, 2011. Link to SFX for this item
5. Zhu, Y. "Estimation of warfarin maintenance dose based on VKORCI (-1639 G > A) and CYP2C9 genotypes." Clinical Chemistry 53.7 (2007): 1199-1205. Link to SFX for this item
6. Adcock, Dorothy M. [Author Reprint Author M. "Effect of Polymorphisms in the cytochrome P450 CYP2C9 gene on warfarin anticoagulation." Archives of pathology 128.12 (2004): 1360-1363. Link to SFX for this item
7. Dunne, A. "A nonlinear mixed effects IVIVC model for multi-release drug delivery systems." Journal of Pharmacokinetics and Pharmacodynamics 35.4 (2008): 423-41. Link to SFX for this item
8. Tabasi, S. "Quality by design, part II: Application of NIR spectroscopy to monitor the coating process for a pharmaceutical sustained release product." Journal of pharmaceutical sciences 97.9 (2008): 4052-4066. Link to Full Text for this item Link to SFX for this item
9. Wallvik, J. "Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics." Scandinavian journal of primary health care 25.2 (2007): 123-8. Link to Full Text for this item Link to SFX for this item
10. Persson, A. "Design and characterization of a new miniaturized rotating disk equipment for in vitro dissolution rate studies." Journal of pharmaceutical sciences 97.8 (2008): 3344-3355. Link to Full Text for this item Link to SFX for this item
11. Posti, J. "Dissolution rate limited bioavailability of flutamide, and in vitro-in vivo correlation." European journal of pharmaceutics and biopharmaceutics 49.1 (2000): 35-39. Link to Full Text for this item Link to SFX for this item
12. Susce, M.T. T. "Response to hydrocodone, codeine and oxycodone in a CYP2D6 poor metabolizer." Progress in neuro-psychopharmacology & biological psychiatry 30.7 (2006): 1356-1358. Link to SFX for this item
13. Sjlander, A. "Risk of haemorrhagic stroke in patients with oral anticoagulation compared with the general population." Journal of internal medicine 254.5 (2003): 434-8. Link to Full Text for this item Link to SFX for this item
14. Tabasi, S. "Quality by design, part III: Study of curing process of sustained release coated products using NIR spectroscopy." Journal of pharmaceutical sciences 97.9 (2008): 4067-4086. Link to Full Text for this item Link to SFX for this item
15. Gasche, Y. "Codeine intoxication associated with ultrarapid CYP2D6 metabolism." The New England journal of medicine 351.27 (2004): 2827-31. Link to SFX for this item
16. Foster, A. "Complicated pain management in a CYP450 2D6 poor metabolizer." Pain practice 7.4 (2007): 352-356. Link to Full Text for this item Link to SFX for this item
17. Systems Pharmacology and Pharmacodynamics. Springer International Publishing :. 1-511. Link to SFX for this item
18. Wallig, Matthew A. A. Haschek and Rousseaux's Handbook of Toxicologic Pathology. Link to SFX for this item
19. Strandgarden, K. "Dissolution rate-limited absorption and complete bioavailability of roquinimex in man." Biopharmaceutics & drug disposition 20.7 (1999): 347-354. Link to Full Text for this item Link to SFX for this item
20. Hughey, Justin R. "The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions." European journal of pharmaceutical sciences 48.4-5 (2013): 758-766. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.